144 related articles for article (PubMed ID: 18431323)
1. Diagnosis and management of primary progressive multiple sclerosis.
Jenkins TM; Khaleeli Z; Thompson AJ
Minerva Med; 2008 Apr; 99(2):141-55. PubMed ID: 18431323
[TBL] [Abstract][Full Text] [Related]
2. Primary progressive multiple sclerosis: progress and challenges.
Rice CM; Cottrell D; Wilkins A; Scolding NJ
J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1100-6. PubMed ID: 23418213
[TBL] [Abstract][Full Text] [Related]
3. The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history.
Sorensen PS; Sellebjerg F; Hartung HP; Montalban X; Comi G; Tintoré M
Brain; 2020 Sep; 143(9):2637-2652. PubMed ID: 32710096
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis of primary progressive multiple sclerosis.
Wolinsky JS;
J Neurol Sci; 2003 Feb; 206(2):145-52. PubMed ID: 12559502
[TBL] [Abstract][Full Text] [Related]
5. Multiple Sclerosis: An Emergency Medicine-Focused Narrative Review.
Pelletier J; Sugar D; Koyfman A; Long B
J Emerg Med; 2024 Apr; 66(4):e441-e456. PubMed ID: 38472027
[TBL] [Abstract][Full Text] [Related]
6. Teaching case: a man with a progressive gait impairment and visual compromise.
Toro J; Burbano LE; Zamora A; Jones E
Mult Scler Relat Disord; 2015 Mar; 4(2):176-9. PubMed ID: 25787194
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome.
Idris MN; Sokrab TE; Ibrahim EA; Ali HE; Elzibair MA; Abadalatif M; Osman RR
Mult Scler; 2009 Dec; 15(12):1537-8. PubMed ID: 20019098
[No Abstract] [Full Text] [Related]
8. Progressive visual function impairment as the predominant symptom of the transition phase to secondary progressive multiple sclerosis: A case report.
Giordano A; Colombo B; Spinelli EG; Gelibter S; Guerrieri S; Leocani L; Comi G; Martinelli V
Mult Scler Relat Disord; 2018 Aug; 24():69-71. PubMed ID: 29957351
[TBL] [Abstract][Full Text] [Related]
9. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis.
Ge Y; Grossman RI; Udupa JK; Wei L; Mannon LJ; Polansky M; Kolson DL
Radiology; 2000 Mar; 214(3):665-70. PubMed ID: 10715027
[TBL] [Abstract][Full Text] [Related]
10. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
Karussis D
J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
[TBL] [Abstract][Full Text] [Related]
11. Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association.
Bigliardi G; Mandrioli J; Valzania F; Nichelli P; Casula N; Simone AM; Sola P
Neurol Sci; 2010 Dec; 31(6):833-6. PubMed ID: 20585817
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with late-onset multiple sclerosis.
Kis B; Rumberg B; Berlit P
J Neurol; 2008 May; 255(5):697-702. PubMed ID: 18283394
[TBL] [Abstract][Full Text] [Related]
13. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.
Boyko A; Therapontos C; Horakova D; Szilasiová J; Kalniņa J; Kolontareva J; Gross-Paju K; Selmaj K; Sereike I; Milo R; Gabelić T; Rot U
Mult Scler Relat Disord; 2021 May; 50():102778. PubMed ID: 33592384
[TBL] [Abstract][Full Text] [Related]
14. Consensus recommendations for the diagnosis and treatment of primary progressive multiple sclerosis in Latin America.
Cristiano E; Rojas JI; Abad P; Adoni T; Barahona J; Becker J; Carrá A; Flores J; Fruns M; Fernández Liguori N; Garcea O; García Bónito J; Giunta D; Gracia F; Hamuy F; Macias Islas MA; Navas C; Boschetti LO; Patrucco L; Sato DK; Correale J
J Neurol Sci; 2018 Oct; 393():4-13. PubMed ID: 30096568
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria for primary progressive multiple sclerosis: a position paper.
Thompson AJ; Montalban X; Barkhof F; Brochet B; Filippi M; Miller DH; Polman CH; Stevenson VL; McDonald WI
Ann Neurol; 2000 Jun; 47(6):831-5. PubMed ID: 10852554
[TBL] [Abstract][Full Text] [Related]
16. Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.
van Walderveen MA; Lycklama A Nijeholt GJ; Adèr HJ; Jongen PJ; Polman CH; Castelijns JA; Barkhof F
Arch Neurol; 2001 Jan; 58(1):76-81. PubMed ID: 11176939
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic criteria of multiple sclerosis with reference to different clinical forms].
Dimitri D
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):914-28. PubMed ID: 11787356
[TBL] [Abstract][Full Text] [Related]
18. [The role of MRI in the diagnosis and the natural course of multiple sclerosis].
Tourbah A; Lyon-Caen O
Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):757-60. PubMed ID: 11677395
[TBL] [Abstract][Full Text] [Related]
19. MRI lesion loads and disability relationships in MS: more similar than different?
Wolinsky JS
Neurology; 2009 Nov; 73(19):1524-5. PubMed ID: 19828867
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.
Sandelius Å; Sandgren S; Axelsson M; Malmeström C; Novakova L; Kostanjevecki V; Vandijck M; Blennow K; Zetterberg H; Lycke J
Sci Rep; 2019 Nov; 9(1):17309. PubMed ID: 31754174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
